Articles

High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel
Department of Pediatric Oncology/Hematology, Charité – Universitätsmedizin Berlin
Department of Pediatric Oncology/Hematology, Charité – Universitätsmedizin Berlin
Department of Pediatric Hematology/Oncology, Medical School Hannover
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel
Department of Hematology, Oncology and Tumor Immunology, HELIOS-Clinic Berlin-Buch, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, HELIOS-Clinic Berlin-Buch, Berlin, Germany
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg
Department of Pediatric Oncology, Hematology and Immunology, Children’s Hospital, University of Heidelberg
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel
Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel;Department of Pediatric Hematology/Oncology, Medical School Hannover
Department of Pediatric Oncology/Hematology, Charité – Universitätsmedizin Berlin
Vol. 99 No. 1 (2014): January, 2014 https://doi.org/10.3324/haematol.2013.090225